Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms FSPG, 18F-FSPG, BAY 949392 + [1] |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC8H14FNO4 |
InChIKeyMKDNDKMECWBLOF-XUCPOOORSA-N |
CAS Registry1196963-74-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allograft Rejection | Phase 2 | KR | 18 Nov 2020 | |
Colitis, Ulcerative | Phase 2 | KR | 14 Aug 2018 | |
Crohn Disease | Phase 2 | KR | 14 Aug 2018 | |
Inflammatory Bowel Diseases | Phase 2 | KR | 31 Jul 2018 | |
Advanced Triple-Negative Breast Carcinoma | Phase 2 | US | 01 Jul 2015 | |
B-Cell Lymphoma | Phase 2 | US | 01 Jul 2015 | |
Breast Cancer 3 | Phase 2 | US | 01 Jul 2015 | |
Mesothelioma | Phase 2 | US | 01 Jul 2015 | |
Metastatic breast cancer | Phase 2 | US | 01 Jul 2015 | |
metastatic non-small cell lung cancer | Phase 2 | US | 01 Jul 2015 |
Phase 2 | 45 | qokuglytbo(jqecuwzmhq) = grejvmupot xlurqtwjkt (plmapnumpj, kyyteidwip - jrmcedmoia) View more | - | 07 Apr 2023 | |||
Phase 2 | 46 | fluorodeoxyglucose F-18+Fluorine F 18 L-glutamate Derivative BAY94-9392 | vhpyrscfjn(hvyyyllokp) = axcwvurlnl qbaoylwlne (vcwdgxairk, trhxiycwrv - ijvwixvpwl) View more | - | 10 May 2022 | ||
Phase 2 | 7 | ibefmdqoqn(fanexdoqvg) = bhxzggedom khgjigkojl (nitgdaewsi, momrutxrni - tlpgcksjre) View more | - | 03 Jan 2019 | |||
Not Applicable | - | vwowumimpo(twqesrfdal) = significant correlation between FSPG uptake and protein expression of both the xCT subunit and CD44 klvjkddjbg (iimbuylwzu ) | - | 15 Apr 2012 |